GlaxoSmithKline
GSK
#213
Rank
โ‚ฌ83.28 B
Marketcap
41,23ย โ‚ฌ
Share price
1.64%
Change (1 day)
25.03%
Change (1 year)

GlaxoSmithKline (GSK) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ18.17 Billion

According to GlaxoSmithKline's latest financial reports the company has โ‚ฌ18.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ15.78 B7.02%
2023-12-31$โ‚ฌ14.74 B29.5%
2022-12-31$โ‚ฌ11.38 B-55.24%
2021-12-31$โ‚ฌ25.43 B10.31%
2020-12-31$โ‚ฌ23.05 B7.31%
2019-12-31$โ‚ฌ21.48 B427.39%
2018-12-31$โ‚ฌ4.07 B3.67%
2017-12-31$โ‚ฌ3.92 B-32.5%
2016-12-31$โ‚ฌ5.82 B-51.62%
2015-12-31$โ‚ฌ12.03 B90.43%
2014-12-31$โ‚ฌ6.31 B-32.28%
2013-12-31$โ‚ฌ9.33 B13.35%
2012-12-31$โ‚ฌ8.23 B-22.08%
2011-12-31$โ‚ฌ10.56 B-6.59%
2010-12-31$โ‚ฌ11.30 B-6.78%
2009-12-31$โ‚ฌ12.13 B39.13%
2008-12-31$โ‚ฌ8.72 B-35.39%
2007-12-31$โ‚ฌ13.49 B-5.74%
2006-12-31$โ‚ฌ14.31 B29.95%
2005-12-31$โ‚ฌ11.01 B26.63%
2004-12-31$โ‚ฌ8.70 B-27.57%
2003-12-31$โ‚ฌ12.01 B6%
2002-12-31$โ‚ฌ11.33 B-17.8%
2001-12-31$โ‚ฌ13.78 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
โ‚ฌ39.45 B 117.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ79.89 B 339.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ44.54 B 145.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ38.40 B 111.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ74.06 B 307.52%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ6.22 B-65.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.45 B-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA